Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cooperative phase IIb trial of MediciNova's MN-166 begins in patients with progressive MS

July 19, 2013

EMA committee recommends orphan drug status for Soliris in rare neurological disease

July 19, 2013

Noscira presents results from the ARGO trial of tideglusib

July 19, 2013

Preliminary data presented for the anti-protofibrillar Abeta MAb SAR-228810

July 19, 2013

Osthole-derived compound has beneficial effects on learning and memory

July 19, 2013

Recruitment begins in Boehringer Ingelheim's phase I trial of BI-409306

July 18, 2013

Novel lisuride analogues disclosed by MAP Pharmaceuticals, now part of Allergan

July 18, 2013

Alkermes commences phase II study of broad-spectrum oral antipsychotic candidate

July 18, 2013

FDA accepts resubmission of NDA for Northera

July 18, 2013

ELND-005 granted FDA fast track designation for NPS in Alzheimer's disease

July 18, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...